Wikidata

(Q62110486)

English

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

clinical trial

In more languages

Statements

title
A 24-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Finding, Safety, Tolerability, and Efficacy Study of the Human Anti-IL-12 Antibody ABT-874 in Subjects With Multiple Sclerosis With a 24-Week Double-Blind, Active Extension Phase (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Canada
0 references
Germany
0 references
Netherlands
0 references
United Kingdom
0 references
start time
April 2004
0 references
end time
November 2006
0 references
number of participants
215
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110486&oldid=2133389111"